120 related articles for article (PubMed ID: 16416851)
1. [Gene therapies for bladder cancer].
Satoh M; Wang H; Arai Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():548-51. PubMed ID: 16416851
[No Abstract] [Full Text] [Related]
2. [Gene therapy for breast cancer].
Miki Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():522-5. PubMed ID: 16416846
[No Abstract] [Full Text] [Related]
3. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858
[TBL] [Abstract][Full Text] [Related]
4. Mesothelioma: an inviting but challenging target for gene therapy.
Crystal RG
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):383-4. PubMed ID: 20228386
[No Abstract] [Full Text] [Related]
5. Gene therapy for superficial bladder cancer.
Rosser CJ; Benedict WF; Dinney CP
Expert Rev Anticancer Ther; 2001 Dec; 1(4):531-9. PubMed ID: 12113085
[TBL] [Abstract][Full Text] [Related]
6. [Prostate cancer gene therapy].
Nasu Y; Kumon H
Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
[TBL] [Abstract][Full Text] [Related]
7. [A preliminary study on construction of targeting double suicide gene therapy vector pcDNA3.1 (-) Cp-CD-TK].
Luo Q; Xiong Y; Lu YZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):983-7. PubMed ID: 20067103
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.
Freund CT; Tong XW; Block A; Contant CF; Kieback DG; Rowley DR; Lerner SP
Anticancer Res; 2000; 20(5A):2811-6. PubMed ID: 11062688
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy for glioma].
Mizuno M; Yoshida J
Nihon Rinsho; 2005 Dec; 63 Suppl 12():562-5. PubMed ID: 16416853
[No Abstract] [Full Text] [Related]
10. [Gene therapy for breast cancer].
Takahashi S; Sugimoto Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():135-41. PubMed ID: 17682150
[No Abstract] [Full Text] [Related]
11. [Effects of double targeting gene therapy by suicide gene combined with endostatin gene in treatment of bladder cancer: an experimental study].
Pan JG; Zhou X; Han RF
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2700-4. PubMed ID: 19080691
[TBL] [Abstract][Full Text] [Related]
12. [Gene therapy for malignant brain tumors--the present conditions and the prospects].
Nakahara N; Yoshida J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():499-503. PubMed ID: 16201571
[No Abstract] [Full Text] [Related]
13. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
14. [Lethal effect of adenovirus-mediated HSV-TK gene in combination with hydroxycamptothecin on human bladder cancer in vitro].
Huang H; Tan WL; Zhu WH; Liang ZK
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):461-4. PubMed ID: 17545031
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy.
Loskog A; Ninalga C; Hedlund T; Alimohammadi M; Malmström PU; Tötterman TH
Lab Anim; 2005 Oct; 39(4):384-93. PubMed ID: 16197705
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy: the challenges of translating laboratory research into clinical practice.
Connell PP; Weichselbaum RR
J Clin Oncol; 2003 Jun; 21(12):2230-1. PubMed ID: 12805319
[No Abstract] [Full Text] [Related]
18. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
[TBL] [Abstract][Full Text] [Related]
19. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
Pagliaro LC; Keyhani A; Williams D; Woods D; Liu B; Perrotte P; Slaton JW; Merritt JA; Grossman HB; Dinney CP
J Clin Oncol; 2003 Jun; 21(12):2247-53. PubMed ID: 12805322
[TBL] [Abstract][Full Text] [Related]
20. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.
Hattori Y; Maitani Y
Cancer Gene Ther; 2005 Oct; 12(10):796-809. PubMed ID: 15891776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
